Objective Although the standard regimen for late preterm birth (LPTB) antenatal
corticosteroids involves two doses of betamethasone given 24 hours apart, not all women …

Background Infants who are born at 34 to 36 weeks of gestation (late preterm) are at greater
risk for adverse respiratory and other outcomes than those born at 37 weeks of gestation or …

CONCLUSION: Half dose did not show noninferiority to full antenatal betamethasone dose
regimen to prevent severe respiratory distress syndrome in preterm neonates. However …

BACKGROUND. A single dose of prenatal betamethasone treatment decreases neonatal
morbidity rates when administered within 7 days before preterm delivery. A single repeat …

Objective Compared to term, late preterm infants are more likely to develop respiratory
morbidity, even after BMZ administration. We sought to identify risk factors for neonatal …

Objective Infants born in the late preterm period are more susceptible to adverse neonatal
outcome, particularly respiratory morbidity, than those born at term. Our objective was to …

Background: Benefits of antenatal corticosteroids have been established for preterm infants
who have received the full course. In imminent preterm labours there is no time to administer …

Background Prenatal glucocorticoids are commonly used in pregnancies before 34 weeks of
gestation in women at risk of preterm delivery; however, the effects of these drugs on late …

Importance Administration of corticosteroids to women at high risk for delivery in the late
preterm period (34-36 weeks' gestation) improves short-term neonatal outcomes. The cost …

Objective: To evaluate whether administration of antenatal late-preterm betamethasone is
cost-effective in the immediate neonatal period. Study design: Cost-effectiveness analysis of …